Cardinal Health, Inc.
NYSE:CAHMedical - Distribution
-$3.77 today
- Market cap
- $64.33B
- Beta
- 0.53
- P/E (TTM)
- 33.5
- EPS (TTM)
- $6.63
- Dividend yield
- 0.92%
Volume 1.35M
Average 2.11M
CAH EBITDA Margin
EBITDA as a percentage of revenue.
Cardinal Health, Inc.NYSE: CAH
EBITDA Margin · Q1 FY2027 · quarter ended Sep 2026
EBITDA Margin holds steady near 1.5%
EBITDA Margin was 1.5% in Q1 FY2027, up 0.1 pp from a year earlier. On a trailing-twelve-month basis it was 1.4%, down 0.0 pp year over year. Over 3 fiscal years it widened by 0.7 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 12 analysts of 1.9% for the fiscal year ending Jun 2027, up from 1.4% in FY2026.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- 1.5%-0.2 pp QoQ
- Last fiscal yearJun 2026
- 1.4%-0.0 pp YoY
- LTMSep 2026
- 1.4%-0.0 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +0.1 pp | +0.7 pp | +0.7 pp |
| 1 year | -0.0 pp | +0.6 pp | +0.6 pp |
| 3 years | +0.7 pp | +0.6 pp | -0.1 pp |
| 5 years | +1.0 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2026
- 1.4%
- Year-over-year change
- -0.0pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2026 | 2026-06-30 | 1.4% | -0.0pp |
| FY2025 | 2025-06-30 | 1.4% | +0.5pp |
| FY2024 | 2024-06-30 | 0.9% | +0.2pp |
| FY2023 | 2023-06-30 | 0.7% | +0.7pp |
| FY2022 | 2022-06-30 | 0.0% | — |
EBITDA Margin vs competitors
How CAH compares with its peers on the latest reported figures
- CAH's LTM Sep 2026 EBITDA Margin of 1.4% is the lowest of the 4 companies compared; the peer median is 1.8%.
- Its year-over-year change of -0.0 pp is the lowest of 4, against a peer median of +0.3 pp.
- Over three fiscal years its change of +0.7 pp compares with a peer median of -0.1 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 7.7% | +0.2 pp | -0.1 pp | |
| LTM Jun 2026 | 1.8% | +0.4 pp | -0.2 pp | |
| LTM Jun 2026 | 1.5% | +0.3 pp | -0.1 pp | |
| LTM Sep 2026 | 1.4% | -0.0 pp | +0.7 pp | |
| Peer median (excluding CAH) | 1.8% | +0.3 pp | -0.1 pp | |
Competitors are the stored peer set for CAH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 | FY2026 Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 181.33B | 204.98B | 226.83B | 222.58B | 254.25B |
| Cost of Revenue | 174.84B | 198.11B | 219.41B | 214.41B | 244.47B |
| Gross Profit | 6.48B | 6.89B | 7.41B | 8.17B | 9.77B |
| Gross Margin | 3.6% | 3.4% | 3.3% | 3.7% | 3.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 4.51B | 4.8B | 5B | 5.38B | 6.13B |
| Operating Expenses | 7.09B | 6.12B | 6.17B | 5.89B | 7.16B |
| Depreciation & Amortization | 692M | 692M | 710M | 790M | 956M |
| EBITDA | 55M | 1.44B | 1.96B | 3.11B | 3.48B |
| EBITDA Margin | 0.0% | 0.7% | 0.9% | 1.4% | 1.4% |
| Operating Income | (607M) | 752M | 1.24B | 2.28B | 2.61B |
| Operating Margin | -0.3% | 0.4% | 0.5% | 1.0% | 1.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 147M | 84M | 51M | 215M | 348M |
| Other Income / Expenses | (177M) | (89M) | (42M) | (174M) | (439M) |
| Income Before Tax | (784M) | 663M | 1.2B | 2.1B | 2.17B |
| Pre-Tax Margin | -0.4% | 0.3% | 0.5% | 0.9% | 0.9% |
| Income Tax Expense | 153M | 332M | 348M | 532M | 469M |
| Net Income | (938M) | 330M | 852M | 1.56B | 1.71B |
| Net Margin | -0.5% | 0.2% | 0.4% | 0.7% | 0.7% |
| EPS (Basic) | (3.34) | 1.26 | 3.48 | 6.48 | 7.27 |
| EPS (Diluted) | (3.34) | 1.26 | 3.45 | 6.45 | 7.23 |
| Weighted Avg Shares | 279M | 261M | 245M | 241M | 236M |
| Weighted Avg Shares (Diluted) | 279M | 262M | 247M | 242M | 237M |
Cardinal Health, Inc.
NYSE:CAH
Intrinsic Alpha fair value
Locked
Current Price
$278.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.